IP Verse

Sandoz competitive analysis

Latest oppositions filed by Sandoz

Explore patent oppositions filed by Sandoz against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 16, 2026

Patent Number	Title	Applicant	Opposition Date
EP4406594	Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs Thereof	F HOFFMANN LA ROCHE	Jun 9, 2026
EP4185318	Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye Disorders	BAYER HEALTHCARE	Jun 1, 2026
EP3756650	Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione	AMGEN EUROPE	May 20, 2026
EP4188389	Methods Of Treating Chronic Kidney Disease With Dapagliflozin	ASTRAZENECA	May 12, 2026
EP3689365	Use Of Long-Acting Glp-1 Peptides	NOVO NORDISK	Apr 28, 2026
EP3470400	Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method Therefor	CRYSTAL PHARMACEUTICAL SUZHOU	Dec 23, 2025
EP4331604	Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell Function	F HOFFMANN LA ROCHE	Nov 28, 2025
EP3800177	Fenfluramine Compositions And Methods Of Preparing The Same	ZOGENIX	Oct 23, 2025
EP3681539	Iron Complex Compounds For Therapeutic Use	PHARMACOSMOS HOLDING	Oct 1, 2025
EP3539540	Pharmaceutical Composition, Methods For Treating And Uses Thereof	BOEHRINGER INGELHEIM	Sep 18, 2025

Latest patents of Sandoz opposed by its competitors

Explore Sandoz's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 16, 2026

Patent Number	Publication Date	Title	Total Oppositions
EP3829682	Dec 4, 2024	An Inhaler Device	1
EP3373914	Jun 1, 2022	Storage Stable Composition Comprising Rifaximin Alpha	1
EP3536311	Dec 22, 2021	Storage Stable Composition Comprising Rifaximin Alpha	1
EP3434265	Jul 7, 2021	Pharmaceutical Composition Containing Rifaximin Alpha & Delta	3
EP3390358	Sep 23, 2020	Crystalline Eravacycline Bis-Hydrochloride	1
EP3416627	Apr 22, 2020	Oral Dosage Form Comprising Rifaximin In Form Beta	1
EP2785702	Jan 22, 2020	Crystalline Dapagliflozin Hydrate	1
EP2975050	May 29, 2019	Quantification Of Misfolded Tnfr2:Fc	1
EP2977372	May 8, 2019	Polymorphs Of Febuxostat	1
EP2988733	Mar 27, 2019	Pharmaceutical Composition Containing Crystalline Macitentan	1

Latest PTAB cases involving Sandoz

Discover the latest PTAB cases involving Sandoz, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 17, 2026

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Sandoz
IPR2023-00478	Feb 3, 2023	SANDOZ	ACERTA PHARMA	Institution Denied
PGR2022-00054	Jul 29, 2022	SANDOZ	BIOGEN MA	Institution Denied
PGR2022-00037	May 2, 2022	SANDOZ	BOEHRINGER INGELHEIM	Institution Denied
IPR2019-00865	Mar 21, 2019	SANDOZ	PHARMACYCLICS	Final Written Decision
IPR2018-00156	Nov 6, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2018-00002	Oct 2, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2018-00002	Oct 2, 2017	SANDOZ	HOFFMAN	Institution Denied
IPR2017-02105	Sep 14, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Terminated-Settled
IPR2017-02105	Sep 14, 2017	SANDOZ	HOFFMAN	Terminated-Settled
IPR2017-02106	Sep 14, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Terminated-Settled

Peer Comparison New

IP litigation analysis comparing Sandoz with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
SANDOZ	128	16	19	-
ABBVIE BIOTECHNOLOGY	-	-	-	22
BOEHRINGER INGELHEIM	34	183	8	9
NOVO NORDISK	9	128	1	9